2024-2029 Global Hemostasis Analyzers and Reagents - USA, Europe, Japan - 2024 Competitive Shares and Growth Strategies, Five-Year Volume and Sales Segment Forecasts for Chromogenic, Immunodiagnostic and Molecular Coagulation Tests - Latest Technologies a

2024-2029 Global Hemostasis Analyzers and Reagents - USA, Europe, Japan - 2024 Competitive Shares and Growth Strategies, Five-Year Volume and Sales Segment Forecasts for Chromogenic, Immunodiagnostic and Molecular Coagulation Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Entry Barriers and Risks

Summary

This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years.

The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.

New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Coagulation Tests Analyzed in the Report

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.

Current and Emerging Products
Review of established and emerging procedures.
Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review
Analysis of current and emerging technologies and their potential market applications.
Companies developing or marketing new technologies and products by test.

Strategic Recommendations
Product development and business expansion opportunities with significant market appeal.
Ideal product models with tentative prices and operating characteristics.
Alternative market penetration strategies for instrument and reagent suppliers.
Potential market entry barriers and risks.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.